Effect of intraoperative blood salvage autotransfusion on the prognosis of patients after carotid body tumor resection.
- Author:
Weihao LI
1
;
Jing LI
1
;
Xuemin ZHANG
1
;
Wei LI
1
;
Qingle LI
1
;
Xiaoming ZHANG
1
Author Information
1. Department of Vascular Surgery, Peking University People's Hospital, Beijing 100044, China.
- Publication Type:Journal Article
- Keywords:
Blood transfusion, autologous;
Carotid body tumor;
Operative blood salvage;
Prognosis
- MeSH:
Humans;
Blood Transfusion, Autologous/methods*;
Operative Blood Salvage/methods*;
Retrospective Studies;
Male;
Female;
Carotid Body Tumor/pathology*;
Middle Aged;
Prognosis;
Neoplasm Recurrence, Local;
Blood Loss, Surgical;
Aged;
Adult;
Operative Time
- From:
Journal of Peking University(Health Sciences)
2025;57(2):272-276
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the effect of intraoperative blood salvage autotransfusion on local recurrence and long-term metastasis of patients after carotid body tumor resection.
METHODS:We retrospectively reviewed a consecutive series of 61 patients undergoing elective carotid body tumor resection from August 2009 to December 2020. Among them, 14 received intraoperative blood salvage autotransfusion (autotrasfusion group) and 47 did not (non-autotransfusion). Data of general information, surgical status and postoperative follow-up results were collected.
RESULTS:The proportion of Shamblin Ⅲ in the autotransfusion group was 85.7%, which was significantly higher than 31.9% in the non-autotransfusion group (P=0.003). The average operation time of the 14 patients in the autotransfusion group was (264±84) min, intraoperative blood loss was 1 200 (700, 2 700) mL, and autologous blood transfusion was 500 (250, 700) mL. Of these, 8 patients (57%) required concomitant allogeneic blood with 400 (260, 400) mL of allogeneic blood. The average operation time of the 47 patients in the non-autotransfusion group was (153±75) min, and the intraoperative blood loss was 300 (100, 400) mL. Of these, 6 (13%) required allogeneic blood transfusion, and 520 (400, 520) mL of allogeneic blood was used. Compared with the non-autotransfusion group, the average operation time in the autologous blood transfusion group was significantly longer (P < 0.001), and the intraoperative blood transfusion volume was larger (P=0.007). Of the 14 patients undergoing autotransfusion, 8 (57%) needed allogeneic blood at the same time; while in the 47 non-autologous transfusion patients, 6 (13%) needed allogeneic blood transfusion. The proportion of autotransfusion group using allogeneic blood at the same time was even higher (P=0.002). The incidence of nerve injury within 30 days after surgery was 29.5%, and there was no significant difference between the two groups. No early deaths occurred. The average follow-up was (76±37) months. One case of local recurrence occurred in the non-autotransfusion group. There was no distant metastasis. There were no tumor-related deaths. The estimated 5-year and 10-year overall survival rates were 96.4% and 83.8%, respectively. There was no significant difference in overall survival between the two groups (P=0.506).
CONCLUSION:The use of intraoperative blood salvage autotransfusion increased no risk of local recurrence and distant metastasis in patients with carotid body tumor, which is safe and effective in carotid body tumor resection.
